Telehealth & Digital Health

A CPG veteran launches Lioness, a functional gummy snack for women. Can timed ingredients and a massive retail launch redefine the wellness market?

A new partnership between PAM Health and Marshall Health Network isn't just building a hospital; it's creating a new healthcare and economic hub for South Point.

Portable oxygen offers freedom, but as companies market summer travel, a closer look reveals that not all devices may deliver on their life-sustaining promise.

Hong Kong's NatureU touts impressive anti-aging results on a public registry, but a closer look reveals a complex strategy blending early science with savvy marketing.

Digital health firm Osara Health is targeting the 'Cancer Care Cliff,' backing its new survivorship program with a validated 25:1 ROI and proven health outcomes.

Zealand Pharma's petrelintide shows double-digit weight loss with remarkably few side effects, positioning it to challenge GLP-1 giants in the $100B market.

DBV Technologies heads to a key investor conference with its VIASKIN patch for peanut allergies. Can its science and strategy convince Wall Street?

Ottawa's new "AI for All" plan promises to revolutionize healthcare, but can its 'ironclad protections' keep pace with the technology it's unleashing?

A small biotech just unveiled data for an oral weight-loss pill that appears twice as effective as a key competitor in early tests, shaking up the market.

Florida Southern College secures a rare 10-year nursing accreditation, signaling a critical boost for a state grappling with a persistent nursing shortage.

With its new SYNMUE™ probiotic, SynbioTech is targeting the biological clock of our immune system. A deep dive into the science, the strategy, and the execution.

With key regulatory decisions pending in Canada and the US, DIAGNOS's CARA AI platform is set to unlock a multi-billion dollar market for early eye disease detection.

Amid a regional healthcare crisis, 475 nurses at BMC South plan to picket, citing unsafe staffing and a 'bullying' contract offer from management.

Landmark trial results for Bayer's KERENDIA unlock a vast new market in non-diabetic kidney disease, offering hope to millions and a strategic win for the firm.

In a move signaling a new era for Chinese healthcare, Fangzhou and Tencent are combining specialized AI with massive tech scale. Is this the blueprint for market dominance?

The DEA is joining forces with 7,000 community coalitions for a landmark summit. We analyze if this new blueprint can finally disrupt the fentanyl crisis.

Swedish innovator Triomed AB unveils a system that triples ultrafiltration in peritoneal dialysis, tackling a critical patient risk and challenging market leaders.

With millions set to lose Medicaid under new federal rules, Azara Healthcare’s acquisition of Advocatia creates a new tech arsenal for at-risk providers.

As Liberty Hill's population skyrockets, the arrival of a freestanding ER ends residents' long drives for urgent care, a milestone for the booming suburb.

A pharma revolution is brewing for Generalized Anxiety Disorder. As prevalence soars, novel therapies targeting new neural pathways promise to upend the market.